phase iii ultimate i & ii update: ublituximab versus teriflunomide in relapsing ms
Published 2 years ago • 187 plays • Length 3:26Download video MP4
Download video MP3
Similar videos
-
3:27
ultimate i & ii results: ublituximab versus teriflunomide in relapsing ms
-
1:41
ublituximab: pending approval for relapsing ms
-
1:52
relapse rate from the ultimate studies of ublituximab for relapsing ms
-
5:42
comparing ublituximab and teriflunomide in improving fatigue in ms
-
1:14
how does ublituximab compare to other anti-cd20 mabs?
-
3:08
novel agents are needed for the treatment of multiple sclerosis
-
1:05
myairvo™2システムの紹介：結露の少ないairspiral™(エアスパイラル)チューブ (japanese)
-
2:25
new cataract treatment: multifocal intraocular lenses.
-
5:54
what wavefront data should you use to select edof iols for patients?
-
1:03
differences between the bd carefusion alaris pcu 8015 and the baxter sigma spectrum
-
0:14
post-dilation of evolut r valve with significant improvement in valve expansion
-
21:14
mastercourse surgery - treatment strategy of peri implantitis surgical method
-
41:14
influenza updates '20 21
-
1:01
a new medical milestone
-
3:45
梅特勒-托利多推出新型 xpe 精密天平。
-
2:00:43
advances in iol technology
-
0:49
music therapy updated
-
13:50
additional new features